These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 32718277)

  • 21. Comparative outcomes between COVID-19 and influenza patients placed on veno-venous extracorporeal membrane oxygenation for severe ARDS.
    Raff LA; Reid TD; Johnson D; Raff EJ; Schneider AB; Charles AG; Gallaher JR
    Am J Surg; 2022 Feb; 223(2):388-394. PubMed ID: 33894980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience of extracorporeal membrane oxygenation for acute respiratory distress syndrome associated with pneumonia in children.
    Peng CC; Wu SJ; Chen MR; Chiu NC; Chi H
    J Formos Med Assoc; 2012 Mar; 111(3):147-52. PubMed ID: 22423668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-infection with influenza-associated acute respiratory distress syndrome requiring extracorporeal membrane oxygenation.
    Rozencwajg S; Bréchot N; Schmidt M; Hékimian G; Lebreton G; Besset S; Franchineau G; Nieszkowska A; Leprince P; Combes A; Luyt CE
    Int J Antimicrob Agents; 2018 Mar; 51(3):427-433. PubMed ID: 29174419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.
    Yang X; Cai S; Luo Y; Zhu F; Hu M; Zhao Y; Zheng R; Li X; Hu B; Peng Z
    Crit Care Med; 2020 Sep; 48(9):1289-1295. PubMed ID: 32427613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of Epstein-Barr virus-deoxyribonucleic acid in the lower respiratory tract for distinguishing critically ill patients from those with influenza-associated pneumonia: A pilot study.
    Bai Y; Guo Y; Chen X; Yang C; Gu L
    Clin Respir J; 2023 Dec; 17(12):1246-1253. PubMed ID: 37823412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracorporeal Membrane Oxygenation for Severe Respiratory Failure During Respiratory Epidemics and Pandemics: A Narrative Review.
    Lim JKB; Qadri SK; Toh TSW; Lin CB; Mok YH; Lee JH
    Ann Acad Med Singap; 2020 Apr; 49(4):199-214. PubMed ID: 32296808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza A (H1N1) vs non-H1N1 ARDS: analysis of clinical course.
    Töpfer L; Menk M; Weber-Carstens S; Spies C; Wernecke KD; Uhrig A; Lojewski C; Jörres A; Deja M
    J Crit Care; 2014 Jun; 29(3):340-6. PubMed ID: 24508203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris.
    Schmidt M; Langouet E; Hajage D; James SA; Chommeloux J; Bréchot N; Barhoum P; Lefèvre L; Troger A; de Chambrun MP; Hékimian G; Luyt CE; Dres M; Constantin JM; Fartoukh M; Leprince P; Lebreton G; Combes A;
    Crit Care; 2021 Oct; 25(1):355. PubMed ID: 34627350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of prone positioning and extracorporeal membrane oxygenation in acute respiratory distress syndrome: A multicenter cohort study and propensity-matched analysis.
    Chang KW; Hu HC; Chiu LC; Chan MC; Liang SJ; Yang KY; Chen WC; Fang WF; Chen YM; Sheu CC; Chang WA; Wang HC; Chien YC; Peng CK; Wu CL; Kao KC;
    J Formos Med Assoc; 2022 Jun; 121(6):1149-1158. PubMed ID: 34740489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ARDS associated with pneumonia caused by avian influenza A H7N9 virus treated with extracorporeal membrane oxygenation.
    Tang X; He H; Sun B; Wan J; Ban C; Zhang C; Wang S; Xia J; Li J; Liu Y; Cao B; Tong Z
    Clin Respir J; 2015 Jul; 9(3):380-4. PubMed ID: 24725670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital survival outcomes in acute respiratory distress syndrome patients receiving veno-venous extracorporeal membrane oxygenation for longer than 28 days: A retrospective study.
    Umei N; Ichiba S; Genda Y; Mase H; Sakamoto A
    Artif Organs; 2021 Dec; 45(12):1533-1542. PubMed ID: 34398471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanical power during extracorporeal membrane oxygenation and hospital mortality in patients with acute respiratory distress syndrome.
    Chiu LC; Lin SW; Chuang LP; Li HH; Liu PH; Tsai FC; Chang CH; Hung CY; Lee CS; Leu SW; Hu HC; Huang CC; Wu HP; Kao KC
    Crit Care; 2021 Jan; 25(1):13. PubMed ID: 33407733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.
    Schmidt M; Zogheib E; Rozé H; Repesse X; Lebreton G; Luyt CE; Trouillet JL; Bréchot N; Nieszkowska A; Dupont H; Ouattara A; Leprince P; Chastre J; Combes A
    Intensive Care Med; 2013 Oct; 39(10):1704-13. PubMed ID: 23907497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporeal membrane oxygenation in acute respiratory distress syndrome due to influenza A (H1N1)pdm09 pneumonia. A single-center experience during the 2013-2014 season.
    Menon N; Perez-Velez CM; Wheeler JA; Morris MF; Amabile OL; Tasset MR; Raschke RA
    Rev Bras Ter Intensiva; 2017; 29(3):271-278. PubMed ID: 28977101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital Outcomes in Patients Who Developed Acute Respiratory Distress Syndrome After Community-Acquired Pneumonia.
    Kasotakis G; Pant P; Patel AD; Ahmed Y; Raghunathan K; Krishnamoorthy V; Ohnuma T
    J Intensive Care Med; 2024 Oct; 39(10):994-1001. PubMed ID: 38659352
    [No Abstract]   [Full Text] [Related]  

  • 36. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.
    Schmidt M; Hajage D; Lebreton G; Monsel A; Voiriot G; Levy D; Baron E; Beurton A; Chommeloux J; Meng P; Nemlaghi S; Bay P; Leprince P; Demoule A; Guidet B; Constantin JM; Fartoukh M; Dres M; Combes A; ;
    Lancet Respir Med; 2020 Nov; 8(11):1121-1131. PubMed ID: 32798468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study.
    Magret M; Lisboa T; Martin-Loeches I; Máñez R; Nauwynck M; Wrigge H; Cardellino S; Díaz E; Koulenti D; Rello J;
    Crit Care; 2011; 15(1):R62. PubMed ID: 21324159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis.
    Zhou Y; Fu X; Liu X; Huang C; Tian G; Ding C; Wu J; Lan L; Yang S
    Sci Rep; 2020 Feb; 10(1):3044. PubMed ID: 32080223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study.
    Roch A; Lepaul-Ercole R; Grisoli D; Bessereau J; Brissy O; Castanier M; Dizier S; Forel JM; Guervilly C; Gariboldi V; Collart F; Michelet P; Perrin G; Charrel R; Papazian L
    Intensive Care Med; 2010 Nov; 36(11):1899-905. PubMed ID: 20721530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of COVID-19 Patients With Acute Respiratory Distress Syndrome Managed With Extracorporeal Membrane Oxygenation at US Academic Centers.
    Nguyen NT; Sullivan B; Sagebin F; Hohmann SF; Amin A; Nahmias J
    Ann Surg; 2021 Jul; 274(1):40-44. PubMed ID: 33843791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.